By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Leveraging its proprietary technology platform to augment therapeutics through effective oral114.57K100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States11.2M100.00%